The following article features coverage from the Society of Gynecologic Oncology’s 50th Annual Meeting on Women’s Cancer. Click here to read more of Cancer Therapy Advisor‘s conference coverage.

Results from a retrospective cohort study performed using data included in the National Cancer Database (NCDB) within the last 10 years show that use of brachytherapy (BT) in black women with locally advanced cervical cancer is lower compared with non-black women. These study findings were presented at the Society of Gynecologic Oncology (SGO)’s 50th Annual Meeting on Women’s Cancer.

Results from a retrospective cohort study performed using data included in the National Cancer Database (NCDB) within the last 10 years show that use of brachytherapy (BT) in black women with locally advanced cervical cancer is lower compared with non-black women. These study findings were presented at the Society of Gynecologic Oncology (SGO)’s 50th Annual Meeting on Women’s Cancer.

The standard-of-care treatment for women with locally advanced cervical cancer involves external beam radiation therapy (EBRT) and chemotherapy followed by BT. In this study, 15,411 women with stage IB2 to IV cervical cancer who had received EBRT and for whom survival data were available were identified using the NCDB. 

Related Articles

The study found that receipt of BT was significantly lower for black compared with non-black women (odds ratio = 0.86; 95% CI, 0.77-0.95; P =.003). In addition, all-cause mortality was higher for black women compared with non-black women with cervical cancer (ie, median overall survival was 52.5 months [95% CI, 0.46-58.6] for black women compared with 65.3 months [95% CI, 61.5-69.5 for non-black women [P <.001]). When comparing black and non-black patients who had received BT, no significant difference in survival were observed (P =0.83).

The study authors concluded that “improving access to BT for black women [with cervical cancer] may improve overall survival.”

Read more of Cancer Therapy Advisor‘s coverage of SGO’s annual meeting meeting by visiting the conference page.

Reference

  1. Alimena S, Yang D, Melamed A, et al. Disparities in utilization and timing of brachytherapy for patients with locally advanced cervical cancer: A National Cancer Database study. Presented at: Society of Gynecologic Oncology (SGO)’s 50th Annual Meeting on Women’s Cancer; Honolulu, Hawaii; March 16-19, 2019. Abstract 11.